Chemoinformaics analysis of 2-(3,4-dihydroxyphenyl)-ethyl-O-beta-D-glucopyranoside
| Molecular Weight | 316.306 | nRot | 5 |
| Heavy Atom Molecular Weight | 296.146 | nRig | 12 |
| Exact Molecular Weight | 316.116 | nRing | 2 |
| Solubility: LogS | -0.83 | nHRing | 1 |
| Solubility: LogP | -1.66 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 43.1319 |
| nHD | 6 | BPOL | 23.5361 |
| QED | 0.359 |
| Synth | 3.567 |
| Natural Product Likeliness | 2.054 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.027 |
| HIA | 0.984 |
| CACO-2 | -5.649 |
| MDCK | 0.00029969 |
| BBB | 0.754 |
| PPB | 0.360481 |
| VDSS | 1.214 |
| FU | 0.662437 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.053 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.088 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.522 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.202 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.021 |
| CL | 3.33 |
| T12 | 0.773 |
| hERG | 0.027 |
| Ames | 0.508 |
| ROA | 0.1 |
| SkinSen | 0.305 |
| Carcinogencity | 0.067 |
| EI | 0.018 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.053 |
| Antiviral | Yes |
| Prediction | 0.848248 |